Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$820M |
| 2 |
Microsoft
MSFT
|
+$811M |
| 3 |
McDonald's
MCD
|
+$804M |
| 4 |
Coca-Cola
KO
|
+$655M |
| 5 |
Amazon
AMZN
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.1B |
| 3 |
Strategy Inc
MSTR
|
+$564M |
| 4 |
Kroger
KR
|
+$558M |
| 5 |
Danaher
DHR
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.33% |
| 2 | Healthcare | 3.23% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 2.55% |
| 5 | Industrials | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BTCZ
11726
T-Rex 2X Inverse Bitcoin Daily Target ETF
BTCZ
$22.1M
| $49.7K | ﹤0.01% |
+14,530
| New | +$63.8K |
|
11727
Swvl Holdings
SWVL
$14.1M
| $49.6K | ﹤0.01% |
+11,637
| New | +$44.6K |
|
|
IBG
11728
Innovation Beverage Group
IBG
$1.69M
| $49.3K | ﹤0.01% |
3,463
+2,726
| +370% | +$46.3K |
|
11729
Xtant Medical Holdings
XTNT
$42.8M
| $49.3K | ﹤0.01% |
66,708
-27,407
| -29% | -$15.6K |
|
11730
Hour Loop
HOUR
$68.3M
| $49.1K | ﹤0.01% |
+34,362
| New | +$44.4K |
|
11731
CALL
Dyadic International
DYAI
$28.2M
| $49.1K | ﹤0.01% |
49,600
+36,600
| +282% | +$40.1K |
|
11732
Guardforce AI
GFAI
$11M
| $49.1K | ﹤0.01% |
+42,694
| New | +$46K |
|
11733
PUT
Inovio Pharmaceuticals
INO
$113M
| $49K | ﹤0.01% |
24,100
+2,700
| +13% | +$5.17K |
|
11734
PUT
Caribou Biosciences
CRBU
$169M
| $49K | ﹤0.01% |
38,900
+10,100
| +35% | +$9.93K |
|
11735
VOC Energy
VOC
$53.9M
| $49K | ﹤0.01% |
17,135
-9,156
| -35% | -$27K |
|
11736
Cheche Group
CCG
$42.4M
| $48.9K | ﹤0.01% |
+1,791
| New | +$51.8K |
|
11737
Fossil Group
FOSL
$329M
| $48.9K | ﹤0.01% |
33,064
-261,188
| -89% | -$329K |
|
11738
Marine Petroleum Trust
MARPS
$9.42M
| $48.8K | ﹤0.01% |
+10,664
| New | +$43.7K |
|
11739
Nephros
NEPH
$50.3M
| $48.6K | ﹤0.01% |
11,890
-134
| -1% | -$358 |
|
|
EPIX
11740
CALL
DELISTED
ESSA Pharma
EPIX
| $48.6K | ﹤0.01% |
28,600
-13,700
| -32% | -$23.1K |
|
|
OSRH
11741
OSR Health
OSRH
$11.1M
| $48.6K | ﹤0.01% |
35,464
+9,874
| +39% | +$13.7K |
|
|
BORR
11742
PUT
Borr Drilling
BORR
$1.37B
| $48.3K | ﹤0.01% |
26,400
-21,600
| -45% | -$40.8K |
|
11743
CALL
BARK
BARK
$91.4M
| $48.2K | ﹤0.01% |
2,740
+1,560
| +132% | +$35.8K |
|
|
SUIG
11744
Sui Group Holdings
SUIG
$62M
| $48.1K | ﹤0.01% |
+26,277
| New | +$44.1K |
|
11745
Millennium Group International
MGIH
$17.3M
| $48K | ﹤0.01% |
30,201
-46,102
| -60% | -$71.3K |
|
11746
Quetta Acquisition Corp Right
QETAR
| $48K | ﹤0.01% |
41,026
-2,518
| -6% | -$3.53K |
|
11747
PUT
FingerMotion
FNGR
$18.7M
| $47.7K | ﹤0.01% |
23,500
+12,200
| +108% | +$29.9K |
|
11748
Aldeyra Therapeutics
ALDX
$94.1M
| $47.7K | ﹤0.01% |
+12,454
| New | +$32.2K |
|
11749
Solarmax Technology
SMXT
$19.5M
| $47.7K | ﹤0.01% |
+3,646
| New | +$49.6K |
|
11750
PUT
Transact Technologies
TACT
$53.2M
| $47.7K | ﹤0.01% |
13,200
+2,200
| +20% | +$7.89K |
|
Similar funds
Ken Griffin's Q2 2025 Portfolio in Review
As of Q2 2025, Ken Griffin held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Griffin withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Walmart Inc worth $401M.
- Ken Griffin's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
- Ken Griffin added most to NVIDIA in Q2 2025, an estimated $820M increase.
- Ken Griffin's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
- Ken Griffin fully exited Kroger in Q2 2025, selling an estimated $558M.
- Ken Griffin's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
- Ken Griffin opened 1,459 new positions and closed 3,524 in Q2 2025.
- Ken Griffin's portfolio value rose 9.2% quarter-over-quarter to $576B.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.